SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Market Gems:Stocks w/Strong Earnings and High Tech. Rank

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: JD Writer who wrote (73601)11/29/1999 6:05:00 PM
From: Street Walker  Read Replies (1) of 120523
 
>WALK, TALK & chew GUMM at the same time.<

very cute!

For those who don't know, GUMM is expecting a release of Second Clinicals. This will validate the previous study that demonstrated ZICAM reducing the cold to 1 1/2 days.
PLUS, the clinicals will demonstrate ZICAM's ability to PREVENT the common cold. This will satisfy the medical community, but the general folk already have conducted their own family trials and have found Zicam to be a miracle treatment.

Everyone who knows the affect of Biotech news on an illness that affects all of humanity, should research GUMM and its products early on ( gumminvestors.com ) so you will know to buy it AFTER it gaps tremendously on the news.<g>

BTW, its product is growing faster than KIDE was growing last year at this time.

Go to your local stores and ask the pharmacists how well it is selling (its sold out in most stores already and it was just re-stocked last Friday).

Costco orders it in cases and they are selling about 1 1/2 cases every two days.

Regards,
S.W.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext